AM4 inhibitors belong to a distinctive chemical class characterized by their ability to selectively target Junctional Adhesion Molecule 4 (JAM4). Junctional adhesion molecules (JAMs) are a family of transmembrane proteins that play crucial roles in various physiological processes, including cell adhesion, migration, and the modulation of immune responses. Among these, JAM4 is a particularly intriguing member due to its involvement in cellular interactions within tissues. The inhibitors designed for JAM4 exert their effects by specifically binding to the active site or regulatory regions of the JAM4 protein, impeding its normal functions. This targeted inhibition is achieved through the careful design of chemical structures that interact with JAM4 in a manner that disrupts its molecular interactions with other cellular components.
JAM4 inhibitors has garnered significant attention in the field of molecular and cell biology, offering a potential avenue for modulating cellular processes. Researchers are actively investigating the structural intricacies of these inhibitors to enhance their specificity and efficacy, paving the way for a deeper understanding of the molecular mechanisms underlying JAM4-related cellular events. The exploration of JAM4 inhibitors not only contributes to our understanding of fundamental biological processes but also holds promise for potential applications in various fields, including the study of cell migration, tissue development, and immune responses.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which can modulate signaling pathways potentially connected to IGSF5 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, which can affect downstream signaling of cellular pathways that IGSF5 may be part of. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MAP kinase kinase (MEK), which could alter signaling cascades involving IGSF5. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which could impact cellular processes that are regulated by IGSF5. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A selective inhibitor of p38 MAPK, potentially affecting signaling pathways where IGSF5 may play a role. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, which could modify the cytoskeleton dynamics associated with IGSF5. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A Src family kinase inhibitor that could influence signaling networks connected to IGSF5. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
An inhibitor of BMP signaling which might intersect with IGSF5-related pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that could affect various cellular processes, potentially including those associated with IGSF5. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
A potent and selective inhibitor of Gs-alpha, possibly affecting signaling cascades that involve IGSF5. | ||||||